A carregar...
Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
AIMS/INTRODUCTION: We aimed to evaluate the potential benefits and adverse effects of adding a mineralocorticoid receptor antagonist (MRA) to angiotensin‐converting enzyme inhibitors (ACEI) and/or angiotensin receptor blockers (ARB), as standard treatment in patients with diabetic nephropathy. MATER...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497036/ https://ncbi.nlm.nih.gov/pubmed/28107779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12629 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|